Symbol | Exchange | Currency |
|---|
Investing.com - OncoCyte (NASDAQ: OCX) reported first quarter EPS of $-0.076, $0.02 better than the analyst estimate of $-0.094. Revenue for the quarter came in at $1.1M versus the...
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that Joshua Riggs has been appointed as its Chief Executive Officer effective February 24,...
OncoCyte Corporation (NYSE:OCX) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares...
Teladoc Health, Inc. (NYSE:TDOC) has signed an agreement to acquire Paris-based telemedicine provider MédecinDirect. The deal is in sync with the company’s effort to...
The market had a fairly good trading day on Wednesday, finishing higher. After some strong early action, and then a pullback, they firmed up. A lot of stocks we follow are doing...
OncoCyte Corporation is a molecular diagnostics company. The Company is focused on developing and commercializing proprietary tests, initially offered as laboratory-developed tests (LDTs), to serve unmet medical needs across the cancer care continuum. The Company’s products include DetermaRx, DetermaIO, and DetermaCNI. DetermaRx is a commercialized predictive molecular test for early-stage adenocarcinoma of the lung. This gene expression-based test provides information that a physician can use to identify early-stage, surgically resected patients with Stage I and IIA non-squamous non-small cell lung cancer (NSCLC). DetermaIO is developed to identify patients to respond to immunotherapy drugs. Its predictive biomarkers, including PD-L1 and Tumor Mutational Burden to predict, which patients responds to immunotherapy. DetermaCNI is a tumor-informed tests that are on market for treatment monitoring as well as blood-only targeted panels.
| Average | 0.825 (+133.051% Upside) |
| High | 1.400 |
| Low | 0.400 |
| Price | 0.354 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 207.46 | 207.79 | 197.20 | +12.18 | +6.24% | 168.62M | NASDAQ | |||
| 164.90 | 165.00 | 161.91 | +2.54 | +1.56% | 67.09M | NASDAQ | |||
| 62.03 | 62.25 | 61.87 | +0.18 | +0.29% | 14.06M | NYSE | |||
| 211.94 | 212.17 | 206.77 | +4.10 | +1.97% | 25.22M | NASDAQ | |||
| 103.73 | 103.89 | 101.04 | +2.84 | +2.81% | 35.75M | NASDAQ | |||
| 289.27 | 289.27 | 283.00 | +5.22 | +1.84% | 32.09M | NASDAQ | |||
| 40.80 | 40.83 | 40.28 | +0.42 | +1.04% | 22.83M | NYSE | |||
| 98.01 | 98.36 | 95.27 | +0.13 | +0.13% | 55.43M | NASDAQ | |||
| 103.29 | 103.49 | 101.95 | +1.29 | +1.26% | 55.70M | NASDAQ | |||
| 166.04 | 166.68 | 164.29 | +3.37 | +2.07% | 1.51M | NASDAQ | |||
| 277.77 | 278.34 | 271.05 | +3.94 | +1.44% | 42.98M | NASDAQ | |||
| 8.45 | 8.48 | 8.08 | +0.30 | +3.68% | 26.17M | NYSE | |||
| 104.00 | 104.19 | 101.44 | +2.68 | +2.65% | 27.08M | NASDAQ | |||
| 47.94 | 48.13 | 45.95 | +1.43 | +3.07% | 13.50M | NYSE | |||
| 52.02 | 52.35 | 51.39 | +0.59 | +1.15% | 20.24M | NASDAQ |